A new study from Ernst and Young has shown that consumers are driving demand for use of digital health technology – but some are unconvinced about pharma innovations such as smart pills.
UK health technology startup Mendelian has received a £500,000 grant from a government agency to build products that will help GPs identify patients with rare or hard to diagnose conditions
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.